| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
116,303 |
104,941 |
$10.99M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
95,054 |
86,390 |
$8.50M |
| G0378 |
Hospital observation service, per hour |
5,212 |
2,928 |
$5.67M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
34,960 |
32,676 |
$3.86M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
41,402 |
38,838 |
$3.69M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
26,565 |
9,251 |
$1.83M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
19,239 |
18,478 |
$1.54M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
20,940 |
19,525 |
$1.42M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
10,505 |
9,803 |
$1.23M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,899 |
4,208 |
$1.05M |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
2,514 |
1,238 |
$970K |
| 80053 |
Comprehensive metabolic panel |
51,417 |
45,951 |
$933K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,483 |
3,393 |
$831K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,019 |
3,027 |
$795K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,810 |
2,718 |
$714K |
| 36415 |
Collection of venous blood by venipuncture |
96,738 |
49,544 |
$707K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
7,362 |
6,676 |
$690K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,484 |
6,443 |
$625K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,926 |
5,621 |
$591K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
5,957 |
5,759 |
$519K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
10,707 |
8,884 |
$515K |
| 99215 |
Prolong outpt/office vis |
4,917 |
4,387 |
$513K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
4,360 |
4,189 |
$484K |
| 87631 |
|
7,588 |
7,328 |
$448K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,946 |
1,794 |
$378K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,281 |
3,268 |
$359K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
4,359 |
1,957 |
$350K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
11,432 |
11,365 |
$343K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,067 |
3,039 |
$343K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
14,989 |
14,134 |
$332K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
436 |
434 |
$292K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
8,160 |
3,270 |
$283K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
3,009 |
1,002 |
$273K |
| 97161 |
|
2,846 |
2,819 |
$242K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,998 |
1,976 |
$236K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,160 |
2,153 |
$218K |
| 17110 |
|
985 |
903 |
$212K |
| 20610 |
|
915 |
884 |
$210K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
349 |
349 |
$188K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
6,518 |
6,351 |
$185K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,576 |
1,572 |
$169K |
| 97162 |
|
1,595 |
1,567 |
$169K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,836 |
2,832 |
$160K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,673 |
5,245 |
$153K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
6,598 |
6,206 |
$151K |
| 76942 |
|
842 |
839 |
$139K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,520 |
958 |
$135K |
| 12001 |
|
352 |
352 |
$134K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
6,517 |
6,350 |
$133K |
| 90686 |
|
5,720 |
5,692 |
$133K |
| 96161 |
|
4,530 |
4,368 |
$126K |
| 80061 |
Lipid panel |
16,664 |
16,542 |
$125K |
| 84443 |
Thyroid stimulating hormone (TSH) |
20,473 |
19,967 |
$123K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,872 |
3,789 |
$119K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
581 |
570 |
$117K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
406 |
403 |
$115K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
8,370 |
7,316 |
$111K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
8,881 |
7,989 |
$111K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
56,018 |
47,990 |
$111K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
371 |
364 |
$106K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
14,536 |
14,362 |
$105K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,729 |
2,647 |
$99K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
314 |
313 |
$93K |
| 59025 |
Fetal non-stress test |
543 |
324 |
$92K |
| 97113 |
|
1,032 |
361 |
$91K |
| 99205 |
Prolong outpt/office vis |
849 |
826 |
$90K |
| 96415 |
|
266 |
214 |
$90K |
| 11102 |
|
204 |
203 |
$87K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,219 |
1,215 |
$85K |
| 27096 |
|
153 |
147 |
$84K |
| 87536 |
|
1,024 |
1,010 |
$81K |
| 92551 |
|
1,558 |
1,552 |
$80K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
797 |
796 |
$80K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
10,515 |
10,098 |
$79K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,720 |
2,677 |
$74K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
3,339 |
1,645 |
$71K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
545 |
527 |
$65K |
| 98926 |
|
2,303 |
2,054 |
$63K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
890 |
319 |
$60K |
| 82607 |
|
6,389 |
6,342 |
$60K |
| 76830 |
Ultrasound, transvaginal |
1,244 |
1,212 |
$60K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
354 |
337 |
$55K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
3,963 |
3,941 |
$53K |
| 76775 |
|
1,325 |
1,292 |
$53K |
| 90670 |
|
2,653 |
2,646 |
$51K |
| 93971 |
|
1,006 |
984 |
$49K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
170 |
169 |
$48K |
| 90715 |
|
1,829 |
1,825 |
$48K |
| 97597 |
|
120 |
92 |
$47K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,602 |
1,533 |
$47K |
| 84439 |
|
6,755 |
6,654 |
$46K |
| 86850 |
|
3,010 |
2,934 |
$45K |
| 88342 |
|
893 |
882 |
$45K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
792 |
790 |
$44K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
10,849 |
10,219 |
$43K |
| 82746 |
|
4,683 |
4,649 |
$43K |
| 90680 |
|
2,155 |
2,150 |
$42K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
395 |
392 |
$41K |
| 97165 |
|
593 |
589 |
$38K |
| 86901 |
|
3,275 |
3,170 |
$35K |
| 82728 |
|
3,590 |
3,520 |
$35K |
| 83655 |
|
2,459 |
2,409 |
$35K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
864 |
857 |
$34K |
| 62323 |
|
83 |
83 |
$34K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
395 |
372 |
$32K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
122 |
122 |
$32K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
923 |
510 |
$31K |
| 87660 |
|
3,929 |
3,789 |
$30K |
| 90633 |
|
1,546 |
1,540 |
$30K |
| 83880 |
|
995 |
938 |
$30K |
| 90698 |
|
1,661 |
1,656 |
$29K |
| 86360 |
|
863 |
853 |
$29K |
| 29581 |
|
634 |
130 |
$29K |
| 93320 |
|
807 |
805 |
$29K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
361 |
358 |
$28K |
| 86900 |
|
3,275 |
3,170 |
$28K |
| 87340 |
|
3,554 |
3,533 |
$28K |
| 86762 |
|
2,144 |
2,137 |
$28K |
| 86480 |
|
469 |
466 |
$27K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
299 |
291 |
$27K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
379 |
379 |
$27K |
| 86803 |
|
3,618 |
3,604 |
$26K |
| 76536 |
|
1,144 |
1,131 |
$25K |
| 87480 |
|
3,411 |
3,291 |
$23K |
| 90723 |
|
984 |
982 |
$22K |
| 90647 |
|
992 |
991 |
$22K |
| 87510 |
|
3,303 |
3,182 |
$21K |
| 93975 |
|
66 |
64 |
$21K |
| 83735 |
|
11,382 |
9,326 |
$20K |
| 90677 |
|
679 |
678 |
$20K |
| 93017 |
|
338 |
334 |
$20K |
| 84403 |
|
877 |
866 |
$20K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
338 |
335 |
$19K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,837 |
2,832 |
$19K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
979 |
967 |
$19K |
| 84153 |
|
1,287 |
1,273 |
$19K |
| 76642 |
|
962 |
954 |
$19K |
| 98925 |
|
911 |
871 |
$19K |
| 99442 |
|
179 |
175 |
$19K |
| 80076 |
|
1,656 |
1,561 |
$19K |
| 0352U |
|
629 |
610 |
$18K |
| 97035 |
|
892 |
364 |
$18K |
| 90688 |
|
633 |
631 |
$17K |
| 84702 |
|
2,477 |
1,844 |
$17K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
25 |
25 |
$17K |
| 71271 |
|
626 |
625 |
$16K |
| 86359 |
|
861 |
851 |
$16K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
577 |
567 |
$16K |
| 94060 |
|
385 |
385 |
$15K |
| 90744 |
|
865 |
861 |
$15K |
| 76937 |
|
94 |
81 |
$15K |
| 82570 |
|
4,236 |
4,090 |
$15K |
| 83540 |
|
4,067 |
3,956 |
$15K |
| 86618 |
|
1,430 |
1,417 |
$15K |
| 84481 |
|
2,110 |
2,071 |
$15K |
| 90707 |
|
684 |
684 |
$14K |
| 88304 |
|
400 |
398 |
$14K |
| 87077 |
|
4,031 |
3,863 |
$14K |
| 83550 |
|
3,869 |
3,758 |
$14K |
| 82043 |
|
3,614 |
3,569 |
$13K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
13,781 |
12,552 |
$13K |
| 71046 |
Radiologic examination, chest; 2 views |
4,621 |
4,502 |
$13K |
| 97535 |
Self-care/home management training, each 15 minutes |
240 |
168 |
$13K |
| 11045 |
|
21 |
12 |
$13K |
| 82803 |
|
428 |
412 |
$12K |
| 83001 |
|
728 |
722 |
$12K |
| 83615 |
|
3,861 |
3,251 |
$11K |
| 99222 |
Initial hospital care, per day, moderate complexity |
121 |
113 |
$11K |
| 93325 |
|
806 |
804 |
$11K |
| 81001 |
|
12,544 |
11,737 |
$11K |
| 90651 |
|
271 |
270 |
$11K |
| 90656 |
|
569 |
568 |
$11K |
| 81025 |
|
3,311 |
3,232 |
$11K |
| 85610 |
|
3,220 |
2,906 |
$10K |
| 93298 |
|
680 |
680 |
$10K |
| 90716 |
|
506 |
506 |
$10K |
| 73221 |
|
37 |
37 |
$10K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
24 |
24 |
$10K |
| 86376 |
|
857 |
853 |
$10K |
| 86592 |
|
4,882 |
4,800 |
$10K |
| 87186 |
|
3,575 |
3,425 |
$9K |
| 10060 |
|
37 |
36 |
$9K |
| 83970 |
|
236 |
233 |
$9K |
| 82670 |
|
386 |
343 |
$9K |
| 86800 |
|
850 |
843 |
$9K |
| 90734 |
|
393 |
392 |
$9K |
| 82947 |
|
2,547 |
2,534 |
$9K |
| 87070 |
|
2,814 |
2,675 |
$9K |
| 90710 |
|
430 |
430 |
$9K |
| 82950 |
|
1,680 |
1,674 |
$8K |
| 83525 |
|
833 |
826 |
$8K |
| 83002 |
|
539 |
514 |
$8K |
| 93970 |
|
25 |
24 |
$8K |
| 86705 |
|
1,440 |
1,431 |
$8K |
| 82977 |
|
2,033 |
1,883 |
$8K |
| 92526 |
|
79 |
37 |
$8K |
| 97150 |
Therapeutic procedure(s), group (2 or more individuals) |
188 |
122 |
$7K |
| 82533 |
|
550 |
516 |
$7K |
| 90696 |
|
310 |
310 |
$6K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,596 |
5,382 |
$6K |
| 71250 |
|
66 |
65 |
$6K |
| 82805 |
|
216 |
208 |
$6K |
| 99221 |
|
82 |
81 |
$6K |
| 36591 |
|
290 |
165 |
$6K |
| 91322 |
|
81 |
81 |
$6K |
| 77066 |
Tomosynthesis, mammo |
100 |
99 |
$6K |
| 85730 |
|
2,151 |
2,064 |
$6K |
| 94726 |
|
432 |
429 |
$6K |
| 86140 |
|
2,750 |
2,338 |
$5K |
| 99443 |
|
48 |
47 |
$5K |
| 12011 |
|
14 |
14 |
$5K |
| 86709 |
|
989 |
985 |
$5K |
| 84100 |
|
1,228 |
717 |
$5K |
| 85027 |
|
2,236 |
2,157 |
$5K |
| 73630 |
|
2,361 |
2,256 |
$5K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
1,146 |
1,115 |
$5K |
| 72100 |
|
935 |
924 |
$5K |
| 97116 |
|
137 |
90 |
$5K |
| 64615 |
|
13 |
13 |
$5K |
| 87641 |
|
182 |
182 |
$5K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
50 |
49 |
$5K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
44 |
43 |
$5K |
| 73030 |
|
1,591 |
1,550 |
$4K |
| 99460 |
|
57 |
56 |
$4K |
| 86225 |
|
1,253 |
1,238 |
$4K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
25 |
13 |
$4K |
| 74183 |
|
14 |
13 |
$4K |
| 86666 |
|
262 |
259 |
$4K |
| 94729 |
|
477 |
474 |
$4K |
| 81003 |
|
7,306 |
7,039 |
$4K |
| 86038 |
|
1,161 |
1,149 |
$4K |
| 84146 |
|
225 |
225 |
$4K |
| 93225 |
|
153 |
153 |
$4K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
80 |
79 |
$4K |
| 99223 |
Prolong inpt eval add15 m |
25 |
24 |
$3K |
| 90700 |
|
133 |
133 |
$3K |
| 84460 |
|
1,055 |
948 |
$3K |
| 84550 |
|
1,122 |
978 |
$3K |
| 82784 |
|
322 |
317 |
$3K |
| 85651 |
|
2,379 |
2,258 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
151 |
115 |
$3K |
| 97166 |
|
37 |
37 |
$3K |
| 83690 |
|
7,977 |
7,376 |
$3K |
| 95806 |
|
73 |
70 |
$3K |
| 86003 |
|
64 |
63 |
$3K |
| 81596 |
|
68 |
68 |
$3K |
| 77080 |
|
64 |
64 |
$3K |
| 86431 |
|
751 |
744 |
$3K |
| 73564 |
|
436 |
432 |
$3K |
| 82247 |
|
945 |
761 |
$3K |
| 99441 |
|
32 |
31 |
$3K |
| 84703 |
|
6,241 |
5,939 |
$3K |
| 90732 |
|
59 |
59 |
$3K |
| 93297 |
|
238 |
238 |
$2K |
| 77065 |
Tomosynthesis, mammo |
44 |
43 |
$2K |
| 70486 |
|
55 |
55 |
$2K |
| 17000 |
|
12 |
12 |
$2K |
| 76882 |
|
95 |
90 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
6,045 |
5,704 |
$2K |
| 86580 |
|
473 |
439 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,001 |
7,242 |
$2K |
| 73130 |
|
1,548 |
1,512 |
$2K |
| 73610 |
|
1,647 |
1,613 |
$2K |
| 84112 |
|
70 |
64 |
$2K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
48 |
25 |
$2K |
| 74178 |
|
12 |
12 |
$2K |
| 87522 |
Neg quan hep c or qual rna |
54 |
52 |
$2K |
| 84450 |
|
647 |
570 |
$2K |
| 85045 |
|
1,118 |
1,041 |
$2K |
| 98927 |
|
79 |
76 |
$2K |
| Q3014 |
Telehealth originating site facility fee |
148 |
141 |
$2K |
| 76000 |
|
13 |
13 |
$2K |
| 87486 |
|
103 |
101 |
$2K |
| 87581 |
|
103 |
101 |
$2K |
| 85018 |
|
2,199 |
2,154 |
$2K |
| 87468 |
|
86 |
85 |
$2K |
| 73562 |
|
620 |
615 |
$2K |
| 87469 |
|
86 |
85 |
$2K |
| 87484 |
|
86 |
85 |
$2K |
| 87478 |
|
86 |
85 |
$2K |
| 82248 |
|
446 |
362 |
$2K |
| 73502 |
|
575 |
550 |
$2K |
| 85652 |
|
1,703 |
1,510 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,528 |
5,478 |
$2K |
| 73110 |
|
795 |
777 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
921 |
844 |
$2K |
| 84156 |
|
637 |
557 |
$1K |
| 84402 |
|
63 |
63 |
$1K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
13 |
13 |
$1K |
| 86706 |
|
271 |
269 |
$1K |
| 73560 |
|
568 |
557 |
$1K |
| 74018 |
|
702 |
670 |
$1K |
| 85007 |
|
1,523 |
1,452 |
$1K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
13 |
13 |
$1K |
| 84484 |
|
5,458 |
4,746 |
$1K |
| 99381 |
|
14 |
12 |
$1K |
| 87640 |
|
189 |
189 |
$1K |
| 80178 |
|
243 |
223 |
$1K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
63 |
25 |
$1K |
| 86696 |
|
74 |
74 |
$1K |
| 84590 |
|
106 |
106 |
$966.95 |
| 84144 |
|
50 |
39 |
$961.79 |
| 80164 |
|
121 |
116 |
$955.63 |
| 87081 |
|
392 |
381 |
$850.41 |
| 85379 |
|
1,147 |
1,129 |
$833.07 |
| 90381 |
|
37 |
37 |
$803.20 |
| 76857 |
|
41 |
38 |
$796.59 |
| C1769 |
Guide wire |
544 |
506 |
$773.47 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,118 |
3,453 |
$769.30 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
436 |
436 |
$732.29 |
| 90694 |
|
78 |
77 |
$730.86 |
| 88307 |
|
12 |
12 |
$721.92 |
| 84480 |
|
173 |
173 |
$716.28 |
| 86765 |
|
64 |
62 |
$713.90 |
| 87040 |
|
987 |
918 |
$703.87 |
| 11721 |
|
61 |
43 |
$630.81 |
| 88341 |
|
35 |
35 |
$630.10 |
| 95911 |
|
12 |
12 |
$611.33 |
| 93242 |
|
100 |
100 |
$609.55 |
| 95886 |
|
39 |
38 |
$560.61 |
| 82150 |
|
185 |
179 |
$536.19 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
40 |
37 |
$530.71 |
| 82550 |
|
249 |
209 |
$496.27 |
| 84425 |
|
41 |
41 |
$480.00 |
| 93295 |
|
25 |
25 |
$459.71 |
| 36416 |
|
17 |
17 |
$445.50 |
| 82565 |
|
167 |
135 |
$434.35 |
| 84132 |
|
612 |
590 |
$418.68 |
| 72040 |
|
75 |
73 |
$417.00 |
| 90480 |
|
95 |
94 |
$370.00 |
| 95885 |
|
38 |
38 |
$368.31 |
| 80047 |
|
17 |
17 |
$361.48 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
6,490 |
6,371 |
$358.63 |
| 84520 |
|
157 |
129 |
$319.40 |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
16 |
12 |
$309.64 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
13 |
13 |
$290.63 |
| 86308 |
|
149 |
147 |
$290.23 |
| 73080 |
|
213 |
210 |
$286.09 |
| 87075 |
|
109 |
98 |
$275.62 |
| G0008 |
Administration of influenza virus vaccine |
117 |
116 |
$267.94 |
| 86753 |
|
52 |
52 |
$265.24 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
39 |
39 |
$264.89 |
| 73590 |
|
113 |
108 |
$228.56 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,906 |
2,847 |
$228.30 |
| 83605 |
|
1,242 |
1,158 |
$203.26 |
| 82172 |
|
15 |
15 |
$197.45 |
| 73100 |
|
44 |
41 |
$178.58 |
| 83010 |
|
17 |
17 |
$176.79 |
| 93270 |
|
24 |
24 |
$172.71 |
| 81002 |
|
2,959 |
2,872 |
$161.76 |
| 84436 |
|
53 |
53 |
$159.60 |
| 94664 |
|
1,379 |
1,274 |
$154.37 |
| 84165 |
|
41 |
41 |
$147.50 |
| 82375 |
|
144 |
141 |
$142.71 |
| 73090 |
|
130 |
124 |
$138.76 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,340 |
1,154 |
$118.32 |
| 74019 |
|
42 |
41 |
$117.00 |
| 82077 |
|
1,742 |
1,632 |
$113.73 |
| 86141 |
|
12 |
12 |
$102.50 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
612 |
594 |
$101.42 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
7,097 |
7,052 |
$91.40 |
| A9270 |
Non-covered item or service |
25,962 |
23,785 |
$90.69 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
9,753 |
8,780 |
$87.09 |
| 73600 |
|
14 |
13 |
$84.68 |
| 87045 |
|
13 |
12 |
$82.06 |
| J2704 |
Injection, propofol, 10 mg |
2,606 |
2,520 |
$76.43 |
| 80143 |
|
1,529 |
1,424 |
$76.38 |
| 82378 |
|
13 |
12 |
$75.84 |
| 94010 |
|
13 |
13 |
$68.65 |
| 83050 |
|
146 |
143 |
$66.86 |
| 73120 |
|
13 |
13 |
$66.66 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,577 |
2,132 |
$61.71 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,009 |
921 |
$60.69 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,023 |
1,450 |
$55.35 |
| 80177 |
|
12 |
12 |
$52.50 |
| 80179 |
|
1,497 |
1,400 |
$51.44 |
| 83721 |
|
135 |
133 |
$49.22 |
| 90461 |
|
4,416 |
4,403 |
$45.28 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,912 |
6,644 |
$44.30 |
| 85014 |
|
43 |
42 |
$44.07 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,429 |
1,194 |
$43.86 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
327 |
326 |
$40.32 |
| 72050 |
|
13 |
13 |
$36.00 |
| 72070 |
|
12 |
12 |
$36.00 |
| 82105 |
|
12 |
12 |
$32.71 |
| 71101 |
|
14 |
14 |
$31.50 |
| 84155 |
|
28 |
27 |
$29.36 |
| 82140 |
|
34 |
27 |
$29.14 |
| 99173 |
|
169 |
168 |
$28.98 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,219 |
1,944 |
$24.22 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
425 |
341 |
$23.48 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,432 |
4,266 |
$22.53 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
961 |
949 |
$22.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
4,206 |
4,050 |
$21.31 |
| 96376 |
|
631 |
576 |
$18.47 |
| 99152 |
|
14 |
14 |
$18.24 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
480 |
417 |
$17.67 |
| 82330 |
|
72 |
71 |
$15.24 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
452 |
448 |
$15.00 |
| 73140 |
|
39 |
39 |
$13.60 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
661 |
651 |
$10.16 |
| 84295 |
|
44 |
43 |
$9.62 |
| 69210 |
|
13 |
12 |
$9.34 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,104 |
1,038 |
$9.27 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
133 |
131 |
$3.00 |
| 82272 |
|
29 |
29 |
$2.88 |
| J2060 |
Injection, lorazepam, 2 mg |
307 |
264 |
$0.56 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
49 |
48 |
$0.22 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
13 |
13 |
$0.20 |
| C1758 |
Catheter, ureteral |
107 |
105 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
155 |
124 |
$0.00 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
62 |
60 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
117 |
116 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
58 |
52 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
101 |
96 |
$0.00 |
| 91300 |
|
15 |
13 |
$0.00 |
| G8984 |
Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals |
59 |
58 |
$0.00 |
| 87634 |
|
29 |
28 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
58 |
51 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
92 |
75 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
45 |
41 |
$0.00 |
| 95852 |
|
99 |
90 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
102 |
97 |
$0.00 |
| 87147 |
|
30 |
30 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
15 |
15 |
$0.00 |
| G8981 |
Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals |
24 |
24 |
$0.00 |
| 96380 |
|
18 |
18 |
$0.00 |
| J7609 |
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
13 |
13 |
$0.00 |
| G8982 |
Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
24 |
24 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
13 |
13 |
$0.00 |
| 96127 |
|
12 |
12 |
$0.00 |